Page last updated: 2024-11-04

rofecoxib and Esophagitis

rofecoxib has been researched along with Esophagitis in 3 studies

Esophagitis: INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.

Research Excerpts

ExcerptRelevanceReference
"To compare the effects of aspirin and rofecoxib when administered with esomeprazole on prostaglandin E(2) production, cyclo-oxygenase-2 expression and proliferating cell nuclear antigen expression in patients with Barrett's oesophagus."2.72The effects of esomeprazole combined with aspirin or rofecoxib on prostaglandin E2 production in patients with Barrett's oesophagus. ( Kaur, B; Levine, D; Sood, S; Traxler, B; Triadafilopoulos, G; Weston, A, 2006)
"Carcinogenesis in Barrett's esophagus (BE) is associated with an increased expression of cyclooxygenase (COX) 2."1.31Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. ( Anderson, MA; Burgart, LJ; Buttar, NS; Krishnadath, KK; Leontovich, O; Lutzke, LS; Pacifico, RJ; Wang, KK; Westcott, JY, 2002)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lugardon, S1
Lapeyre-Mestre, M1
Montastruc, JL1
Triadafilopoulos, G1
Kaur, B1
Sood, S1
Traxler, B1
Levine, D1
Weston, A1
Buttar, NS1
Wang, KK1
Leontovich, O1
Westcott, JY1
Pacifico, RJ1
Anderson, MA1
Krishnadath, KK1
Lutzke, LS1
Burgart, LJ1

Trials

1 trial available for rofecoxib and Esophagitis

ArticleYear
The effects of esomeprazole combined with aspirin or rofecoxib on prostaglandin E2 production in patients with Barrett's oesophagus.
    Alimentary pharmacology & therapeutics, 2006, Apr-01, Volume: 23, Issue:7

    Topics: Adult; Aged; Aspirin; Barrett Esophagus; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhi

2006

Other Studies

2 other studies available for rofecoxib and Esophagitis

ArticleYear
Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database.
    European journal of clinical pharmacology, 2004, Volume: 60, Issue:9

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Celecoxib; Cyclooxygenase 2; Cyclo

2004
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus.
    Gastroenterology, 2002, Volume: 122, Issue:4

    Topics: Adenocarcinoma; Animals; Barrett Esophagus; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxyg

2002